Biotech Values

[rfj1862]

Dew,

I'm not going to get into this argument--in fact, I haven't even evaluated the claims because I wouldn't touch NVGN with a ten-foot pole--but you would be suprised at the sheer lack of qualifications among those that write press releases, particularly at the smaller biotech companies.

There are numerous examples of inaccurate, incomplete, and potentially misleading press releases that can be attributed to incompetence on behalf of the writer. Remember the Supergen debacle a couple years ago? The stock dropped 30% or so in one day because the press release neglected to specify whether the results were signficant or not. I didn't follow the ultimate outcome.

John